Johnson and Johnson to exit insulin pump market

Tuesday, 16 January 2018

Johnson and Johnson (JNJ) have announced their intention to exit the insulin pump market globally.

AMSL Diabetes will continue to offer the full range of Dexcom CGM, Lifescan blood glucose meters, HypoPak fast acting glucose and accessory products.

If you currently have an Animas pump ASML will support users for the length of their warranty. There are still Animas pumps available for purchase. Any new pumps will also be supported for the four year warranty period.

Consumables will continue to be available on the NDSS for the foreseeable future.

For more information on how this announcement may affect you please contact AMSL Diabetes on 1300 851 056 or email

Keywords: CGMInsulin pumps

Join our community of over 45,000 people living with diabetes